Differential neuropsychiatric symptom responses to tacrine in Alzheimer's disease: relationship to dementia severity.

Keywords

Tacrine, Apathy, Disinhibition, Alzheimer's disease, Disease

References

• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International WorkshopIan G. McKeith — 2006
• Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer's disease.Dag Aarsland, Jeffrey L. Cummings, G Yenner — 1996
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianMarshal F. Folstein, Susan E. Folstein, Paul R. McHugh — 1975
• Overview of depression and psychosis in Alzheimer's disease.R E Wragg, Dilip V. Jeste — 1989
• Physostigmine ameliorates the delusions of Alzheimer's disease.Jeffrey L. Cummings, David G. Gorman, Jill Shapira — 1993
• Tacrine in Alzheimer's diseaseSarah Eagger, Raymond Levy, Barbara J. Sahakian — 1992
• Effect of Tacrine on Behavioral Symptoms in Alzheimer's Disease: An Open-Label StudyDaniel Kaufer, Jeffrey L. Cummings, Dianne Christine — 1996
• Psychometric discrimination of tetrahydroaminoacridine responders in Alzheimer patients.Kari Alhainen, Eeva‐Liisa Helkala, Paavo Riekkinen — 1993
• Evidence of a Monoaminergic‐Cholinergic Imbalance Related to Visual Hallucinations in Lewy Body DementiaElaine K. Perry, Elizabeth Marshall, Janet Kerwin — 1990
• Influence of feelings of burden on the caregiver's perception of the patient's functional status.Carlos A. Mangone, R.M. Sanguinetti, Patricia D. Baumann — 1993
• The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer's diseaseKari Alhainen, E.-L. Helkala, K. Reinikainen — 1993
• The cholinergic hypothesis of geriatric memory dysfunction.Raymond T. Bartus, Reginald L. Dean, Bernard Beer — 1982
• Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.Elaine K. Perry, B. E. Tomlinson, G. Blessed — 1978
• Lewy-body dementia and responsiveness to cholinesterase inhibitors: a paradigm for heterogeneity of Alzheimer's disease?Paolo Liberini, Alessandra Valerio, Maurizio Memo — 1996
• Possible neurotransmitter basis of behavioral changes in alzheimer's diseaseAlan M. Palmer, Gary C. Stratmann, Andrew Procter — 1988
• Topographical distribution of neurochemical changes in Alzheimer's disease.Andrew Procter, Stephen L. Lowe, Alan M. Palmer — 1988
• Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity.David A. McCormick — 1992
• The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease.Steven E. Arnold, Bradley T. Hyman, J Flory — 1991
• THA--historical aspects, review of pharmacological properties and therapeutic effects.Jair C. Soares, Samuel Gershon — 1995
• Tacrine: a pharmacological review.Shirley E. Freeman, R. M. C. Dawson — 1991

Cited by

• [Neuropsychiatric inventory questionnaire (NPI-Q): Spanish validation of an abridged form of the Neuropsychiatric Inventory (NPI)].Merçé Boada, Juan Carlos Cejudo, Lluís Tárraga — 2002
• Long-Term Management of DementiaD. Scharre — 2011
• Apathy: a separate syndrome from depression in dementia? A critical reviewMoyra E. Mortby, Andreas Maercker, Simon Forstmeier — 2012
• Leczenie choroby Alzheimera: czy istnieją możliwości przewidywania klinicznej odpowiedzi na inhibitory cholinesterazy?Marcin Flirski, Iwona Kłoszewska, Tomasz Sobów — 2006
• Complex phenotypic analysis to identify genes which contribute to or modify the development of Alzheimer's diseasePaul Hollingworth — 2006
• Epidemiology and Management of Apathy in Patients with Alzheimer’s DiseaseRomina Mizrahi, Sergio Starkstein — 2007
• Treating Apathy in Alzheimer’s DiseasePatricia A. Boyle, Paul Malloy — 2003
• Psychosis due to neurologic conditionsDavid B. Arciniegas, Jeannie Topkoff, Kerri Held — 2001
• Role of Cholinesterase Inhibitors in Managing Behavioral Problems in Alzheimer's Disease.Donna Masterman — 2004
• Neuropsychiatric assessment of Alzheimer’s disease and related dementiasJeffrey L. Cummings, Susan McPherson — 2001
• Cholinesterase Inhibitor Therapies and Neuropsychiatric Manifestations of Alzheimer’s DiseaseZakiya J. Wynn, Jeffrey L. Cummings — 2003
• Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression.Martin R. Farlow, Ann Marie Hake, John Messina — 2001
• Cholinesterase inhibitors for behavioral disturbance in dementiaElla Daly, William E. Falk, Patrick R. Brown — 2001
• The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease.Jeffrey L. Cummings, Carla Back — 1998
• The role of cholinergic agents in the management of behavioural disturbances in Alzheimer's disease.Jeffrey L. Cummings — 2000
• Pharmacological Treatment of Psychosis and Agitation in Elderly Patients with DementiaSandra S. Kindermann, Christian R. Dolder, Anne Bailey — 2002
• Pharmacological Treatment of Apathy in Neurodegenerative Diseases: A Systematic ReviewRosa L. Drijgers, Pauline Aalten, Ania Winogrodzka — 2009
• Principles of neuropsychiatry: Towards a neuropsychiatric epistemologyJeffrey L. Cummings — 1999
• Pharmacologic treatment of apathy in dementia.Karen F. Berman, Henry Brodaty, Adrienne Withall — 2012
• Apathy in Alzheimer's DiseaseAllan M. Landes, Susan D. Sperry, Milton E. Strauss — 2001

Related papers

• Effects of bis(7)-tacrine, a novel anti-Alzheimer's agent, on rat brain AChE.Hong Wang, Paul R. Carlier, Wing Lok Ho — 1999
• Apathy and Disinhibition Related to Neuropathology in Amnestic Versus Behavioral DementiasLetizia G. Borges, Alfred Rademaker, Eileen H. Bigio — 2019
• Behavioral-variant frontotemporal dementiaClaire O’Connor, Ramón Landín-Romero, Lindy Clemson — 2017
• Caregiver Burden in Frontotemporal Degeneration and Corticobasal SyndromeNicole M. Armstrong, Nicole Schupf, Jordan Grafman — 2013
• What a load of rankersSue Perankin — 2009
• Apathy and executive dysfunction in mild cognitive impairment and Alzheimer disease.Rebecca E. Ready, Brian R. Ott, Janet Grace — 2003
• Apathy and Executive Dysfunction in Mild Cognitive Impairment and Alzheimer DiseaseR. E. Ready — 2003